ArticleG3 (Bethesda, Md.)2026
Comparative analysis of draper mutant alleles and RNAi expression systems in the ovary and brain of Drosophila melanogaster.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The phagocytic receptor Draper (Drpr) mediates clearance of apoptotic cells in Drosophila melanogaster, yet how distinct drpr alleles and RNAi constructs differ in efficiency and phenotypic outcomes has not been systematically compared. Here, we evaluate multiple drprRNAi lines across UAS/GAL4, QUAS/QF2, and LexA/LexAop systems, alongside a newly generated CRISPR allele (drprCR1). Immunostaining confirmed efficient protein knockdown for all RNAi lines, while qRT-PCR revealed variable transcript reduction, with short hairpin (SH) constructs more effective in glia and long hairpin (LH) constructs likely acting at the translational level. Despite these differences, all RNAi lines caused strong phenotypes with persisting nurse cell nuclei in the ovary, and apoptotic cell persistence and neurodegenerative vacuoles in the brain, with SH constructs producing more severe defects. The newly generated drprCR1, which selectively deletes exons 5 to 6, abolished full-length Drpr-I while preserving shorter isoforms. Unlike the widely used drprΔ5 allele, drprCR1 uncouples ovarian and brain phenotypes: Both alleles display ovarian defects, but drprCR1 shows markedly reduced neurodegeneration compared to drprΔ5. Together, our findings reveal construct- and allele-specific differences in RNAi knockdown and drpr isoform function, demonstrating that full-length Drpr is indispensable for ovarian cell clearance but less critical for neurodegeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.